Study of clinical and morphological features in resistant hypertension

   The results of the analysis, the study of clinical and morphological features in resistant hypertension. Hypotheses of clinical and morphological features of resistant hypertension are described. The problems of arterial hypertension (AH) are determined by its high frequency in the population, its impact on the health, working capacity and life expectancy of the population. The prevalence of hypertension is 15-30 %, and in people over 65 it exceeds 60 % [URL: https://moluch.ru/archive/236/54737/]. The presence of elevated blood pressure (BP), especially systolic, is associated with an increased risk of coronary heart disease, strokes, heart and kidney failure, that is, complications. In patients with hypertension, an increase in total mortality was revealed by 2-5 times, and mortality from cardiovascular diseases by 2-3 times [URL: https://moluch.ru/archive/236/54737/ ]. Therefore, the development of tactics for the diagnosis and prevention of complications of hypertension is one of the important problems of modern cardiology. A large number of antihypertensive drugs of various groups creates certain difficulties in choosing the optimal medication for blood pressure correction and prevention of complications. According to the literature and recent studies, a high incidence of hypertension has been found in individuals with complications of target organs [URL: https://moluch.ru/archive/236/54737/ ]. Thanks to the doctor's attentiveness and the method of specific and sensitive diagnostics, we can prevent complications during hypertension. With age, this pathology becomes resistant to standard therapy, and this threatens to undesirable consequences in the introduction of the patient, which can lead to complications, disability, and also fatal outcomes for patients are not excluded.

1. Klimov A. V. Arterial'naja gipertenzija i eerasprostranennost' sredi naselenija / A. V. Klimov, E. N. Denisov, O. V. Ivanova. — Tekst: neposredstvennyj // Molodojuchenyj. — 2018. — № 50 (236). — S. 86-90. — URL: https://moluch.ru/archive/236/54737/

2. Kushhova R. R. Rezistentnaja arterial'naja gipertenzija: rasprostranennost' i taktika vedenija tema dissertacii i avtoreferatapo VAK RF 14. 01. 04

3. Koltover A. N., Ljudkovskaja T. S., Gulevskaja T. S. i dr. Gipertonicheskaja angiojencefalopatija v patologoanatomicheskom aspekte // Zhurn. nevropatol. ipsihiatr. 1984. - № 7. – S. 1016-1020.

4. Kadochkina N. G. Rezistentnajaarterial'naja gipertenzija / N. G. Kadochkina. – Gomel'.: GU «RNPC RMiJeCh», 2018. – S. 40.

5. Lohmatkina N. V. Ostrye narushenija mozgovogo krovoobrashhenija v obshhej vrachebnoj praktike // Zhurnal Rossijskji semejnyj vrach. Tekst nauchnoj stat'i po special'nosti «Klinicheskaja medicina», 2018. N 1. S. 19-28.

6. Nartaeva A. E., Djo A. G., Ajnitdinova H. N. Cerebrovaskuljarnye zabolevanija // Vestnik Kaz NMU. 18 Mart 2013. - S. 19 – 28.

7. Strukov A. I., Serov V. V. Patologicheskaja anatomija - 5-e izdanie. - M.: Litterra, 2010. — 848 s.

8. Surzhko G. V. Ostroe narushenie mozgovogo krovoobrashhenija kak faktor v vozniknovenii kliniko-psihologicheskih rasstrojstv / G. V. Surzhko. - Tekst: neposredstvennyj // Molodoj uchenyj. - 2015. - № 10 (90). - S. 462-464. - URL: https://moluch.ru/archive/90/18654/ (data obrashhenija: 16. 08. 2022).

9. Suslina Z. A. Narushenija mozgovogo krovoobrashhenija: diagnostika, lechenie, profilaktika. – M.: MEDpress-inform, 2016. – 536 s.: il. ISBN 978-5-00030-305-4.

10. Shirokov E. A. Individual'nyj prognoz v preventivnoj angionevrologii / E. A. Shirokov // Zhurnal nevrologii i psihiatriiim. S. S. Korsakova. – 2007. – Т. 107. – №. 6. – S. 91-98.

11. Bravata D. M. et al. Long-term mortaliry in cerebrovascular disease.Stroke. 2003; 34.

12. Barber P. A., Darby D. G., Desmond P. M., et al. Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI // Neurology. - 2011. - Vol. 51. - P. 418 - 426.

13. Chalela J. A., Merino J. G., Warach S. Update on stroke // Curr. Opin. Neurol. - 2008. - Vol. 17. - P. 447 - 451.

14. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee // Cerebrovasc. Dis. 2008. V. 25. P. 457.

15. Flemming K. D., Brown R. D. Jr. Cerebral infarction and transient ischemic attacks. Efficient evaluation is essential to beneficial intervention // Postgrad. Med. – 2000. – Vol. 107, № 6. – P. 55 – 62.

16. Guidelines for the Early Management of Adults with Ischemic Stroke // Stroke. – 2007. – Vol. 38. – P. 1655.

17. Jauch E. et. al. Guidelines for the Early Management of Patients with Acute Ischemic Stroke A. Guideline for Healthcare Professionals from the American Heart Association / American Stroke Association. Stroke. 2013; 44: publishedonline January 31.

18. Stefano Ricci, Maria GraziaCelani, Teresa Anna Cantisani et al. Piracetam for acute ischaemic stroke // Cochrane Database of Systematic Reviews - 2006. - № 2.

19. The European Stroke Initiative Executive Committee and the EUSI Writing Committee: European stroke initiative recommendations for stroke management – update 2003. Cerebrovascular Disease 2003; 16: 311-337.

20. Woessner R., Treib J. Ischemic or hemorrhagic stroke? Rapid diagnosis improves prognosis for the patient. MMW Fortschr. Med. 2002.

21. Ziganshina L. E., Abakumova T., Kuchaeva A. Cerebrolysin for acuteischaemic stroke // Cochrane Database of Systematic Reviews. - 2010. - № 4.